Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study. Issue 1 (4th June 2021)

• Record Type: Journal Article
• Authors: Taylor, Joanne Kathryn; Ndiaye, Haarith; Daniels, Matthew; Ahmed, Fozia
• Is Part Of: Open heart. Volume 8:Issue 1(2021)
• Publication Date: 2021-06-04
• Subjects: pacemaker -- artificial -- defibrillators -- implantable -- COVID-19 -- heart failure; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; Heart -- Diseases -- Patients -- Periodicals; 616.12005
• DOI: 10.1136/openhrt-2021-001600
• Languages: English
• ISSNs: 2398-595X

Abstract

Abstract : Aims: In response to the COVID-19 pandemic, the UK was placed under strict lockdown measures on 23 March 2020. The aim of this study was to quantify the effects on physical activity (PA) levels using data from the prospective Triage-HF Plus Evaluation study. Methods: This study represents a cohort of adult patients with implanted cardiac devices capable of measuring activity by embedded accelerometery via a remote monitoring platform. Activity data were available for the 4 weeks pre-implementation and post implementation of 'stay at home' lockdown measures in the form of 'minutes active per day' (min/day). Results: Data were analysed for 311 patients (77.2% men, mean age 68.8, frailty 55.9%. 92.2% established heart failure (HF) diagnosis, of these 51.2% New York Heart Association II), with comorbidities representative of a real-world cohort. Post-lockdown, a significant reduction in median PA equating to 20.8 active min/day was seen. The reduction was uniform with a slightly more pronounced drop in PA for women, but no statistically significant difference with respect to age, body mass index, frailty or device type. Activity dropped in the immediate 2-week period post-lockdown, but steadily returned thereafter. Median activity week 4 weeks post-lockdown remained significantly lower than 4 weeks pre-lockdown (p≤0.001). Conclusions: In a population of predominantly HF patients with cardiac devices, activity reduced by approximately 20 min active per day in the immediate aftermath of strict COVID-19 lockdown measures. Trial registration number: NCT04177199 .